CARE Ratings schedules investor meets for Q4FY26
CARE Ratings Limited has scheduled analyst and institutional investor meets on June 9 and June 17, 2026, to discuss Q4FY26 performance. The company confirmed no unpublished price sensitive information will be shared, and discussions will rely on publicly available documents.

*this image is generated using AI for illustrative purposes only.
CARE Ratings Limited has scheduled a series of analyst and institutional investor meets to discuss its performance for Q4FY26. The meetings will take place on June 9 and June 17, 2026, providing an opportunity for funds and research houses to engage with the company's management. The company confirmed that no unpublished price sensitive information (UPSI) will be shared during these interactions.
The schedule includes a virtual meeting with 12 Flags on June 9, 2026, starting at 1:30 PM. This will be followed by an in-person meeting with Fair Value Capital on June 17, 2026, commencing at 12:00 Noon. The company noted that changes to the schedule may occur due to exigencies on the part of the participants or the company.
Discussions during the meets will be based on publicly available documents. The Investor Presentation for Q4 and FY26 has already been made available on the company's official website. Manoj Kumar CV, Company Secretary & Compliance Officer, signed the intimation regarding these events.
The following table outlines the confirmed schedule for the investor meets:
| Date | Time | Fund/Research House | Meeting Type |
|---|---|---|---|
| 09th June 2026 | 1:30 PM Onwards | 12 Flags | Virtual |
| 17th June 2026 | 12:00 Noon Onwards | Fair Value Capital | In-person |
The disclosure was made pursuant to the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Historical Stock Returns for CARE Ratings
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.56% | -2.97% | -4.95% | +5.10% | -11.66% | +180.76% |
What are the key performance indicators investors should focus on during the Q4FY26 review?
How might the outcomes of these meetings influence CARE Ratings' stock price in the short term?
What strategic initiatives is CARE Ratings likely to highlight for the upcoming fiscal year?


































